Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 4/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.49 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.49 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.49 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.49 |
| ▸ | RARG | P13631 | 1/20 | 0.49 |
| ▸ | CNR1 | P21554 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25681603 | 0.85 | ALDH1A1 (0.56) | ALDH1A1L3MBTL1MAPK1MEN1KMT2A | |
| SCHEMBL13296294 | 0.84 | KMT2A (0.56) | ALDH1A1L3MBTL1MAPK1MEN1KMT2A | |
| SCHEMBL5555546 | 0.84 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1MAPK1MEN1KMT2A | |
| SCHEMBL5538472 | 0.84 | L3MBTL1 (0.54) | ALDH1A1L3MBTL1MAPK1MEN1KMT2A | |
| SCHEMBL23643788 | 0.83 | ALDH1A1 (0.59) | ALDH1A1L3MBTL1MAPK1MEN1KMT2A | |
| SCHEMBL10068188 | 0.83 | ALDH1A1 (0.61) | ALDH1A1L3MBTL1MAPK1MEN1KMT2A | |
| SCHEMBL18171769 | 0.83 | PPID (0.64) | ALDH1A1L3MBTL1MAPK1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL715023 | 0.83 | L3MBTL1 (0.53) | ALDH1A1L3MBTL1MAPK1MEN1KMT2A | |
| SCHEMBL9391884 | 0.83 | MEN1 (0.55) | ALDH1A1L3MBTL1MAPK1MEN1KMT2A | |
| SCHEMBL4073528 | 0.83 | TPSAB1 (0.53) | ALDH1A1L3MBTL1MAPK1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210214374-A1 | COMPOUNDS AND COMPOSITIONS FOR OCULAR DELIVERY | Graybug Vision, Inc. (US) | 2021-07-15 | — | — | US | disclosed |
| US-20210040111-A1 | DRUGS TO TREAT OCULAR DISORDERS | Graybug Vision, Inc. (US) | 2021-02-11 | — | — | US | disclosed |
| US-7582280-B2 | Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications | BRACCO INTERNATIONAL B.V. (NL) | 2009-09-01 | — | — | US | disclosed |
| US-7582280-B2 | Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications | BRACCO INTERNATIONAL B.V. (NL) | 2009-09-01 | — | — | US | disclosed |
| US-7582280-B2 | Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications | BRACCO INTERNATIONAL B.V. (NL) | 2009-09-01 | — | — | US | disclosed |
| US-20080274048-A1 | CONJUGATES OF ANTIOXIDANTS WITH METAL CHELATING LIGANDS FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | BRACCO INTERNATIONAL B.V. (NL) | 2008-11-06 | — | — | US | disclosed |
| US-20080274048-A1 | CONJUGATES OF ANTIOXIDANTS WITH METAL CHELATING LIGANDS FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | BRACCO INTERNATIONAL B.V. (NL) | 2008-11-06 | — | — | US | disclosed |
| US-20080274048-A1 | CONJUGATES OF ANTIOXIDANTS WITH METAL CHELATING LIGANDS FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | BRACCO INTERNATIONAL B.V. (NL) | 2008-11-06 | — | — | US | disclosed |
| US-7407644-B2 | Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications | BRACCO INTERNATIONAL B.V. (NL) | 2008-08-05 | — | — | US | disclosed |
| US-7407644-B2 | Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications | BRACCO INTERNATIONAL B.V. (NL) | 2008-08-05 | — | — | US | disclosed |
| US-7407644-B2 | Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications | BRACCO INTERNATIONAL B.V. (NL) | 2008-08-05 | — | — | US | disclosed |
| US-20070086944-A1 | CONJUGATES OF ANTIOXIDANTS WITH METAL CHELATING LIGANDS FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | BRACCO INTERNATIONAL B.V. (NL) | 2007-04-19 | — | — | US | disclosed |
| US-20070086944-A1 | CONJUGATES OF ANTIOXIDANTS WITH METAL CHELATING LIGANDS FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | BRACCO INTERNATIONAL B.V. (NL) | 2007-04-19 | — | — | US | disclosed |
| US-7160535-B2 | Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications | BRACCO INTERNATIONAL BV (NL) | 2007-01-09 | — | — | US | disclosed |
| US-7160535-B2 | Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications | BRACCO INTERNATIONAL BV (NL) | 2007-01-09 | — | — | US | disclosed |
| US-20040082767-A1 | Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic allications | BRACCO INTERNATIONAL B.V. (NL) | 2004-04-29 | — | — | US | disclosed |
| EP-1406669-A2 | CONJUGATES OF AN ANTIOXIDANTS WITH METAL CHELATING LIGANDS | Bracco International B.V. (NL) | 2004-04-14 | — | — | EP | disclosed |
| WO-2002040060-A2 | CONJUGATES OF AN ANTIOXIDANTS WITH METAL CHELATING LIGANDS | BRACCO INTERNATIONAL BV (NL) | 2002-05-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210040111-A1 | DRUGS TO TREAT OCULAR DISORDERS | PDE6C, AGER, PDE6A | ALDH1A1 761/4885L3MBTL1 4382/4885MAPK1 1067/4885 |
| US-20080274048-A1 | CONJUGATES OF ANTIOXIDANTS WITH METAL CHELATING LIGANDS FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | SOD3, CAT, SOD1 | ALDH1A1 440/4885L3MBTL1 2084/4885MAPK1 4801/4885 |
| US-20040082767-A1 | Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic allications | SOD1, GPX1, GPX4 | ALDH1A1 252/4885L3MBTL1 1722/4885MAPK1 4792/4885 |
| US-20210214374-A1 | COMPOUNDS AND COMPOSITIONS FOR OCULAR DELIVERY | KDR, RB1, PDE6C | ALDH1A1 2125/4885L3MBTL1 4766/4885MAPK1 785/4885 |
| US-20070086944-A1 | CONJUGATES OF ANTIOXIDANTS WITH METAL CHELATING LIGANDS FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | SOD3, CAT, SOD1 | ALDH1A1 440/4885L3MBTL1 2084/4885MAPK1 4801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.